Bristol-Myers Squibb Co.
BMY Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
$BMY is featured in our Lobbying Spending Growth and Tom Carper strategies.
All StrategiesIncome
Balance Sheet
Cash Flow
Revenue Breakdown
Recent trades of BMY by members of U.S. Congress
BMY Stock Insider Trading Activity
Follow @QuiverQuant for major insider updates
---
Closing Price
Purchase
Sale
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
BMY Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
BMY Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in BMY holdings by institutional investors
Quarterly net insider trading by BMY's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Backtest Start Date
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Subscribe to Quiver Premium for insider trading alerts
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$3,160,000 Jul 20, 2026 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$1,320,000 Apr 20, 2026 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)
-
$1,250,000 Jan 20, 2026 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)
-
$3,180,000 Oct 20, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Pharmacy Trade (domestic/foreign)
-
$4,780,000 Jul 21, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Pharmacy Trade (domestic/foreign)
-
$870,000 Apr 20, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Pharmacy
-
$790,000 Jan 21, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Pharmacy Trade (domestic/foreign)
-
$3,250,000 Oct 21, 2024 Issue: Trade (domestic/foreign) Pharmacy Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$640,000 Jul 22, 2024 Issue: Pharmacy Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$80,000 May 28, 2024 Issue: Medicare/Medicaid Health Issues
-
$2,060,000 Jan 21, 2024 Issue: Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$2,180,000 Oct 20, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
-
$2,230,000 Jul 19, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$640,000 Jan 20, 2023 Issue: Budget/Appropriations Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$870,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$1,590,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$2,300,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$730,000 Feb 07, 2022 Issue: None
-
$710,000 Jan 20, 2022 Issue: None
-
$1,740,000 Oct 20, 2021 Issue: None
-
$2,230,000 Jul 20, 2021 Issue: None
-
$1,090,000 May 17, 2021 Issue: None
-
$730,000 Apr 20, 2021 Issue: None
-
$1,600,000 Oct 19, 2020 Issue: None
-
$2,160,000 Jul 20, 2020 Issue: None
-
$540,000 Apr 20, 2020 Issue: None
-
$690,000 Jan 17, 2020 Issue: None
-
$1,240,000 Oct 17, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$970,000 Jul 19, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,200,000 Apr 19, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$940,000 Jan 18, 2019 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
-
$960,000 Oct 19, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,130,000 Jul 18, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
-
$800,000 Apr 18, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$860,000 Jan 18, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
-
$900,000 Oct 18, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
-
$860,000 Jul 17, 2017 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Budget/Appropriations
-
$990,000 Apr 19, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
-
$560,000 Jan 19, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$670,000 Nov 29, 2016 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Budget/Appropriations
-
$810,000 Oct 19, 2016 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$690,000 Apr 19, 2016 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$780,000 Jan 18, 2016 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$850,000 Oct 19, 2015 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$670,000 Jul 20, 2015 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$610,000 Apr 17, 2015 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$770,000 Jan 16, 2015 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$680,000 Oct 17, 2014 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$775,000 Jul 17, 2014 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$520,000 Apr 17, 2014 Issue: Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
-
$740,000 Jan 17, 2014 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$542,000 Oct 18, 2013 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign)
-
$724,000 Jul 16, 2013 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Trade (domestic/foreign)
-
$830,000 Apr 18, 2013 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
-
$1,280,000 Jan 22, 2013 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$520,000 Oct 17, 2012 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$820,000 Jul 18, 2012 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$660,000 Jul 18, 2012 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$870,000 Jan 18, 2012 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$660,000 Oct 18, 2011 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$560,000 Jul 20, 2011 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$1,040,000 Jul 19, 2011 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$509,000 Jul 19, 2011 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$795,000 Oct 19, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$980,000 Jul 19, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$1,060,000 Apr 19, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$860,000 Apr 19, 2010 Issue: Welfare Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$952,580 Oct 20, 2009 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Budget/Appropriations Consumer Issues/Safety/Products Welfare
-
$809,000 Jul 16, 2009 Issue: Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Welfare
-
$814,676 Apr 17, 2009 Issue: Welfare Consumer Issues/Safety/Products Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$1,025,520 Jan 21, 2009 Issue: Law Enforcement/Crime/Criminal Justice Clean Air and Water (quality) Medical/Disease Research/Clinical Labs Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$840,000 Oct 16, 2008 Issue: Law Enforcement/Crime/Criminal Justice Medical/Disease Research/Clinical Labs Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Clean Air and Water (quality)
-
$830,000 Jul 21, 2008 Issue: Clean Air and Water (quality) Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medical/Disease Research/Clinical Labs
-
$840,000 Apr 18, 2008 Issue: Clean Air and Water (quality) Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Copyright/Patent/Trademark Agriculture Trade (domestic/foreign) Taxation/Internal Revenue Code
-
$2,660,000 Mar 12, 2008 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Agriculture Trade (domestic/foreign) Copyright/Patent/Trademark
-
$2,840,000 Sep 17, 2007 Issue: Trade (domestic/foreign) Agriculture Taxation/Internal Revenue Code Health Issues Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations
-
$2,980,000 Feb 12, 2007 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$2,760,000 Aug 10, 2006 Issue: Advertising Clean Air and Water (quality) Torts Medical/Disease Research/Clinical Labs Pharmacy Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Economics/Economic Development Environment/Superfund Insurance Consumer Issues/Safety/Products Government Issues Energy/Nuclear Telecommunications Foreign Relations Food Industry (safety, labeling, etc.) Labor Issues/Antitrust/Workplace Law Enforcement/Crime/Criminal Justice
-
$2,580,000 Feb 14, 2006 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)
-
$2,460,000 Aug 11, 2005 Issue: Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs Torts
-
$2,860,000 Feb 11, 2005 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Foreign Relations Medicare/Medicaid Budget/Appropriations Insurance Government Issues Torts
-
$2,720,000 Aug 13, 2004 Issue: Health Issues Foreign Relations Clean Air and Water (quality) Advertising Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Insurance Consumer Issues/Safety/Products Government Issues Food Industry (safety, labeling, etc.) Torts
-
$2,740,000 Feb 12, 2004 Issue: Advertising Clean Air and Water (quality) Torts Food Industry (safety, labeling, etc.) Taxation/Internal Revenue Code Copyright/Patent/Trademark Economics/Economic Development Health Issues Foreign Relations Medicare/Medicaid Budget/Appropriations Insurance Consumer Issues/Safety/Products Government Issues Trade (domestic/foreign)
-
$2,580,000 Aug 07, 2003 Issue: Advertising Clean Air and Water (quality) Torts Food Industry (safety, labeling, etc.) Government Issues Consumer Issues/Safety/Products Insurance Budget/Appropriations Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Economics/Economic Development Health Issues Foreign Relations
-
$2,420,000 Mar 14, 2003 Issue: None
-
$2,480,000 Aug 01, 2002 Issue: Advertising Law Enforcement/Crime/Criminal Justice Clean Air and Water (quality) Medical/Disease Research/Clinical Labs Pharmacy Labor Issues/Antitrust/Workplace Government Issues Copyright/Patent/Trademark Telecommunications Taxation/Internal Revenue Code Health Issues Foreign Relations Consumer Issues/Safety/Products Medicare/Medicaid Budget/Appropriations Environment/Superfund Insurance Economics/Economic Development Trade (domestic/foreign)
-
$2,400,000 Feb 14, 2002 Issue: Foreign Relations Health Issues Medicare/Medicaid Telecommunications Copyright/Patent/Trademark Economics/Economic Development Budget/Appropriations Environment/Superfund Insurance Consumer Issues/Safety/Products Government Issues Labor Issues/Antitrust/Workplace Pharmacy Medical/Disease Research/Clinical Labs Clean Air and Water (quality) Law Enforcement/Crime/Criminal Justice Advertising Trade (domestic/foreign) Taxation/Internal Revenue Code
-
$2,460,000 Aug 14, 2001 Issue: Advertising Law Enforcement/Crime/Criminal Justice Clean Air and Water (quality) Medical/Disease Research/Clinical Labs Pharmacy Labor Issues/Antitrust/Workplace Government Issues Consumer Issues/Safety/Products Insurance Foreign Relations Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Telecommunications Budget/Appropriations Environment/Superfund
-
$2,220,000 Aug 01, 2001 Issue: Law Enforcement/Crime/Criminal Justice Environment/Superfund Budget/Appropriations Medicare/Medicaid Foreign Relations Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Consumer Issues/Safety/Products Government Issues Clean Air and Water (quality)
-
$2,440,000 Aug 10, 2000 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Foreign Relations Medicare/Medicaid Trade (domestic/foreign) Budget/Appropriations Environment/Superfund Consumer Issues/Safety/Products Government Issues Energy/Nuclear Clean Air and Water (quality) Law Enforcement/Crime/Criminal Justice
-
$2,020,000 Feb 10, 2000 Issue: Law Enforcement/Crime/Criminal Justice Clean Air and Water (quality) Environment/Superfund Budget/Appropriations Medicare/Medicaid Foreign Relations Government Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Consumer Issues/Safety/Products Energy/Nuclear
-
$1,600,000 Aug 10, 1999 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Foreign Relations Medicare/Medicaid Budget/Appropriations Environment/Superfund Consumer Issues/Safety/Products Government Issues Energy/Nuclear Clean Air and Water (quality) Law Enforcement/Crime/Criminal Justice
Former government officials who have lobbied for BMY
85 former government officials from 52 congressional offices at 18 lobbying firms have lobbied for BMY, most recently Aug 04, 2026.
-
Matthew Mcginley House New Chief of Staff, Rep. Tom Price; Chief of Staff, Republican Policy Committee; DCOS & LD, Rep. Brian Kerns -
Paul Brathwaite Congress Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; Special Assistant, U.S. Secretary of Labor, Department of Labor.
-
Ven Neralla House New Chief of Staff, U.S. Rep. Andy Levin; Deputy Chief of Staff,U.S. Rep. Pramila Jayapal; Legislative Director, U.S. Rep.Barbara Lee; Legislative Assistant, U.S. Rep. Peter DeFazio;Senior Advisor, USDA; OPP; and MCC. -
Kaade Wallace Senate New Legislative Correspondent, U.S. Senator Amy Klobuchar; Staff Assistant, U.S. Representative Betty McCollum -
Stacey Leavandosky House New Chief of Staff, U.S. Representative Zoe Lofgren; Senior Advisor, Committee on Science, Space & Technology; Senior Advisor, Committee on House Administration; Executive Director, California Democratic Congressional Delegation -
Eric Bergren House Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker -
Katherine Cotton House Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
-
Paul Edattel House Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
BMY Estimated quarterly lobbying spending
BMY Revenue by Segment or Geography
By Segment
By Geography
BMY Income Statement
BMY Balance Sheet
BMY Cash Flow
U.S. Patents
New BMY patent grants
-
Patent Title: [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds Apr. 23, 2024
-
Patent Title: [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds Apr. 02, 2024
-
Patent Title: [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds Mar. 26, 2024
-
Patent Title: Oxazolidinones as modulators of mglur5 Nov. 28, 2023
-
Patent Title: Substituted nitrogen containing compounds Oct. 17, 2023
-
Patent Title: Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonists Jan. 03, 2023
-
Patent Title: Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifnα responses Apr. 07, 2020
-
Patent Title: Method of treating cd155 expressing cancers Jun. 12, 2018
-
Patent Title: Ip-10 antibodies and their uses Jun. 12, 2018
-
Patent Title: Radioligands for imaging the lpa-1 receptor Jun. 05, 2018
-
Patent Title: Alkyl-amide-substituted pyridyl compounds useful as modulators of il-12, il-23 and/or ifnα responses Jun. 05, 2018
-
Patent Title: Lactam-containing compounds and derivatives thereof as factor xa inhibitors May. 22, 2018
-
Patent Title: Substituted pyridinones as mgat2 inhibitors May. 22, 2018
-
Patent Title: Enantioselective synthesis of pyrroloindole compounds May. 15, 2018
-
Patent Title: Furopyridine compounds for the treatment of hepatitis c May. 01, 2018
-
Patent Title: Imidazo-pyridazine derivatives as casein kinase 1 δ/ϵ inhibitors May. 01, 2018
-
Patent Title: Dihydropyridone p1 as factor xia inhibitors Apr. 24, 2018
-
Patent Title: Immunomodulators Apr. 17, 2018
-
Patent Title: Substituted tetrahydroisoquinoline compounds as factor xia inhibitors Apr. 17, 2018
-
Patent Title: Cyclopropanecarboxylic acid gpr120 modulators Apr. 10, 2018
-
Patent Title: Quinoline-based kinase inhibitors Apr. 03, 2018
-
Patent Title: Methods for reducing glycoprotein aggregation Mar. 27, 2018
-
Patent Title: Phthalazinones and isoquinolinones as rock inhibitors Mar. 27, 2018
-
Patent Title: Targeted therapeutics based on engineered proteins that bind egfr Mar. 20, 2018
-
Patent Title: Triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidase Mar. 20, 2018
-
Patent Title: Cyanoamino (aza)benzofuran compounds for the treatment of hepatitis c Mar. 20, 2018
-
Patent Title: Crystalline forms of a factor xia inhibitor Mar. 20, 2018
-
Patent Title: Indole carboxamide compounds Mar. 20, 2018
-
Patent Title: Ammonium derivatives for the treatment of hepatitis c Mar. 20, 2018
-
Patent Title: Tricyclic pyrido-carboxamide derivatives as rock inhibitors Mar. 13, 2018
-
Patent Title: 6h-furo[2,3-e]indole compounds for the treatment of hepatitis c Mar. 13, 2018
-
Patent Title: Compositions monovalent for cd28 binding and methods of use Mar. 06, 2018
-
Patent Title: Multivalent fibronectin based scaffold domain proteins Feb. 27, 2018
-
Patent Title: Macrocycles as factor xia inhibitors Feb. 27, 2018
-
Patent Title: Flange extender Nov. 07, 2017
-
Patent Title: Flange extender Nov. 07, 2017
-
Patent Title: Flange extender Aug. 01, 2017
-
Patent Title: Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv and method Apr. 30, 2013
-
Patent Title: Epothilone derivatives Dec. 06, 2011
-
Patent Title: Aziridinyl-epothilone compounds Nov. 15, 2011
-
Patent Title: Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b Mar. 01, 2011
-
Patent Title: Epothilone derivatives Nov. 02, 2010
-
Patent Title: Epothilone derivatives Oct. 26, 2010
-
Patent Title: Epothilone derivatives Oct. 26, 2010
-
Patent Title: Treatment of refractory tumors using epothilone derivatives Jun. 22, 2010
-
Patent Title: Handle for injector Apr. 13, 2010
-
Patent Title: Overcap for injector Apr. 06, 2010
-
Patent Title: Overcap for injector Apr. 06, 2010
-
Patent Title: Handle for injector Apr. 06, 2010
-
Patent Title: Injector Mar. 23, 2010
Government Contracts
Federal grants, loans, and purchases
- $0 2026-08-27 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-08-06 00:00:00 Agency: Department of Veterans Affairs
- $378,650 2026-08-06 00:00:00 Agency: Department of Veterans Affairs
- $51,333 2026-08-02 00:00:00 Agency: Department of Veterans Affairs
- $300,000 2026-08-02 00:00:00 Agency: Department of Veterans Affairs
- $199,047 2026-08-02 00:00:00 Agency: Department of Veterans Affairs
- $10,888 2026-07-31 00:00:00 Agency: Department of Veterans Affairs
- $16,422 2026-07-15 00:00:00 Agency: Department of Veterans Affairs
- $138,257 2026-07-07 00:00:00 Agency: Department of Veterans Affairs
- $10,888 2026-07-07 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-06-30 00:00:00 Agency: Department of Veterans Affairs
- $11,977 2026-06-26 00:00:00 Agency: Department of Veterans Affairs
- $16,422 2026-06-18 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-06-16 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-06-16 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-06-16 00:00:00 Agency: Department of Veterans Affairs
- $10,888 2026-06-15 00:00:00 Agency: Department of Veterans Affairs
- $16,768 2026-06-11 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-06-02 00:00:00 Agency: Department of Veterans Affairs
- $11,977 2026-05-29 00:00:00 Agency: Department of Veterans Affairs
- $149,436 2026-05-29 00:00:00 Agency: Department of Veterans Affairs
- $10,888 2026-05-27 00:00:00 Agency: Department of Veterans Affairs
- $16,422 2026-05-21 00:00:00 Agency: Department of Veterans Affairs
- $16,422 2026-05-21 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-05-14 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-05-08 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-05-08 00:00:00 Agency: Department of Veterans Affairs
- $10,888 2026-05-07 00:00:00 Agency: Department of Veterans Affairs
- $6,164 2026-04-29 00:00:00 Agency: Department of Veterans Affairs
- $138,603 2026-04-29 00:00:00 Agency: Department of Veterans Affairs
- $5,814 2026-04-29 00:00:00 Agency: Department of Veterans Affairs
- $364,139 2026-04-24 00:00:00 Agency: Department of Veterans Affairs
- $16,422 2026-04-23 00:00:00 Agency: Department of Veterans Affairs
- $11,319 2026-04-20 00:00:00 Agency: Department of Justice
- $11,319 2026-04-20 00:00:00 Agency: Department of Justice
- $10,888 2026-04-16 00:00:00 Agency: Department of Veterans Affairs
- $6,164 2026-04-07 00:00:00 Agency: Department of Veterans Affairs
- $138,694 2026-04-07 00:00:00 Agency: Department of Veterans Affairs
- $0 2026-04-07 00:00:00 Agency: Department of Veterans Affairs
- $16,422 2026-03-20 00:00:00 Agency: Department of Veterans Affairs
- $10,888 2026-03-20 00:00:00 Agency: Department of Veterans Affairs
- $10,888 2026-03-09 00:00:00 Agency: Department of Veterans Affairs
- $16,422 2026-03-09 00:00:00 Agency: Department of Veterans Affairs
- $5,814 2026-03-06 00:00:00 Agency: Department of Veterans Affairs
- $6,164 2026-03-05 00:00:00 Agency: Department of Veterans Affairs
- $127,169 2026-02-26 00:00:00 Agency: Department of Veterans Affairs
- $338,933 2026-02-19 00:00:00 Agency: Department of Veterans Affairs
- $6,164 2026-02-17 00:00:00 Agency: Department of Veterans Affairs
- $33,190 2026-02-17 00:00:00 Agency: Department of Veterans Affairs
- $183,452 2026-02-17 00:00:00 Agency: Department of Veterans Affairs
Government Contracts
Estimated quarterly amount awarded to BMY from public contracts
BMY News
Recent insights relating to BMY
CNBC Recommendations
Recent picks made for BMY stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in BMY
BMY Analyst Ratings
BMY Stock Forecasts
...
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
BMY Analyst Forecasts
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
Frequently Asked Questions
- Is $BMY stock a Buy, Sell, or Hold?
- What is the price target for $BMY stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
BMY Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
Frequently Asked Questions
- Who owns $BMY stock?
- Who owns the most shares of $BMY stock?
- What funds own $BMY stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
BMY Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view BMY Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
About BMY
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
- Address Princeton, NJ
- Market Cap 124.9 billion
- Employees 32,500
- Industrial Classification Pharmaceutical Preparations
Bristol-Myers Squibb Co. (BMY) Historical Stock Prices
Bristol-Myers Squibb Co. (BMY) closed at $61.15 on September 23, 2026. Over the past year its adjusted close ranged from $41.22 to $68.09. Daily prices go back to January 2, 2014, 3,200 trading days in all.
- 1 month-9.11%
- 3 months+12.39%
- Year to date+17.17%
- 1 year+42.65%
- 3 years+19.53%
- 5 years+24.60%
- Max+77.13%
See every congressional and insider trade on the BMY price chart
Quiver Premium charts BMY's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | 62.31 | 62.65 | 61.08 | 61.15 | 61.15 | 15,843,190 |
| Sep 22, 2026 | 62.73 | 63.08 | 62.03 | 62.25 | 62.25 | 15,237,705 |
| Sep 21, 2026 | 63.09 | 63.40 | 62.62 | 62.62 | 62.62 | 6,839,126 |
| Sep 18, 2026 | 62.71 | 63.06 | 62.19 | 63.06 | 63.06 | 36,849,552 |
| Sep 17, 2026 | 64.08 | 64.35 | 62.52 | 62.84 | 62.84 | 12,212,909 |
| Sep 16, 2026 | 64.07 | 64.39 | 63.22 | 63.60 | 63.60 | 9,449,055 |
| Sep 15, 2026 | 63.94 | 64.13 | 63.15 | 63.73 | 63.73 | 9,996,309 |
| Sep 14, 2026 | 64.59 | 65.29 | 63.91 | 64.10 | 64.10 | 6,903,983 |
| Sep 11, 2026 | 64.15 | 64.20 | 63.27 | 63.64 | 63.64 | 7,055,795 |
| Sep 10, 2026 | 64.92 | 64.92 | 63.73 | 63.75 | 63.75 | 6,495,866 |
| Sep 9, 2026 | 64.57 | 65.05 | 64.26 | 64.41 | 64.41 | 6,573,962 |
| Sep 8, 2026 | 65.66 | 65.89 | 64.39 | 64.69 | 64.69 | 9,524,772 |
| Sep 4, 2026 | 67.24 | 67.72 | 66.58 | 66.82 | 66.82 | 4,825,447 |
| Sep 3, 2026 | 68.08 | 68.24 | 66.61 | 68.09 | 68.09 | 6,224,199 |
| Sep 2, 2026 | 66.81 | 67.73 | 66.75 | 67.66 | 67.66 | 7,825,377 |
| Sep 1, 2026 | 67.58 | 68.04 | 66.64 | 66.92 | 66.92 | 6,933,599 |
| Aug 31, 2026 | 66.25 | 67.20 | 65.91 | 66.81 | 66.81 | 12,682,245 |
| Aug 28, 2026 | 66.77 | 66.84 | 66.19 | 66.58 | 66.58 | 5,543,592 |
| Aug 27, 2026 | 66.59 | 67.47 | 66.20 | 66.95 | 66.95 | 4,670,518 |
| Aug 26, 2026 | 67.73 | 68.00 | 67.32 | 67.57 | 67.57 | 7,511,744 |
| Aug 25, 2026 | 66.42 | 68.05 | 66.42 | 67.92 | 67.92 | 7,912,517 |
| Aug 24, 2026 | 67.41 | 67.41 | 66.45 | 67.28 | 67.28 | 6,812,747 |
| Aug 21, 2026 | 65.79 | 67.55 | 65.13 | 67.01 | 67.01 | 6,841,684 |
| Aug 20, 2026 | 67.22 | 67.54 | 65.45 | 65.47 | 65.47 | 9,489,633 |
| Aug 19, 2026 | 66.80 | 68.64 | 66.61 | 67.61 | 67.61 | 13,889,244 |
| Aug 18, 2026 | 65.30 | 66.38 | 65.00 | 66.05 | 66.05 | 9,413,981 |
| Aug 17, 2026 | 63.60 | 64.74 | 63.36 | 64.63 | 64.63 | 7,289,180 |
| Aug 14, 2026 | 64.13 | 64.33 | 63.35 | 63.83 | 63.83 | 7,529,830 |
| Aug 13, 2026 | 64.05 | 65.02 | 63.91 | 64.65 | 64.65 | 10,526,098 |
| Aug 12, 2026 | 63.49 | 64.00 | 63.00 | 63.70 | 63.70 | 7,509,595 |
| Aug 11, 2026 | 64.56 | 65.02 | 63.54 | 63.61 | 63.61 | 9,366,682 |
| Aug 10, 2026 | 64.33 | 65.25 | 64.12 | 64.84 | 64.84 | 9,753,263 |
| Aug 7, 2026 | 64.24 | 64.73 | 63.79 | 64.72 | 64.72 | 7,212,878 |
| Aug 6, 2026 | 64.90 | 64.94 | 63.20 | 64.15 | 64.15 | 9,553,636 |
| Aug 5, 2026 | 64.81 | 65.41 | 63.26 | 63.63 | 63.63 | 14,117,061 |
| Aug 4, 2026 | 64.89 | 66.31 | 63.87 | 65.89 | 65.89 | 23,292,832 |
| Aug 3, 2026 | 66.12 | 68.10 | 64.14 | 65.47 | 65.47 | 32,970,930 |
| Jul 31, 2026 | 65.00 | 65.66 | 63.53 | 65.31 | 65.31 | 14,580,254 |
| Jul 30, 2026 | 62.69 | 65.56 | 62.23 | 64.86 | 64.86 | 18,031,392 |
| Jul 29, 2026 | 63.87 | 63.91 | 63.10 | 63.10 | 63.10 | 10,609,223 |
| Jul 28, 2026 | 63.65 | 64.97 | 63.20 | 63.60 | 63.60 | 15,143,332 |
| Jul 27, 2026 | 62.40 | 63.44 | 62.22 | 62.56 | 62.56 | 10,318,187 |
| Jul 24, 2026 | 61.94 | 62.82 | 61.60 | 62.09 | 62.09 | 12,071,701 |
| Jul 23, 2026 | 60.74 | 62.05 | 60.45 | 61.51 | 61.51 | 7,621,784 |
| Jul 22, 2026 | 61.40 | 61.70 | 60.56 | 60.76 | 60.76 | 6,796,829 |
| Jul 21, 2026 | 60.08 | 61.02 | 59.80 | 60.93 | 60.93 | 7,744,558 |
| Jul 20, 2026 | 60.76 | 61.35 | 60.02 | 60.16 | 60.16 | 10,183,934 |
| Jul 17, 2026 | 60.87 | 62.29 | 60.47 | 60.74 | 60.74 | 12,261,477 |
| Jul 16, 2026 | 58.79 | 60.55 | 58.57 | 60.51 | 60.51 | 10,166,781 |
| Jul 15, 2026 | 57.05 | 59.19 | 57.04 | 58.72 | 58.72 | 12,485,328 |
| Jul 14, 2026 | 59.00 | 59.14 | 56.78 | 56.95 | 56.95 | 14,056,029 |
| Jul 13, 2026 | 57.90 | 59.44 | 57.54 | 59.34 | 59.34 | 12,089,315 |
| Jul 10, 2026 | 57.79 | 57.94 | 56.94 | 57.58 | 57.58 | 11,203,566 |
| Jul 9, 2026 | 57.44 | 58.00 | 57.14 | 57.94 | 57.94 | 7,628,832 |
| Jul 8, 2026 | 57.89 | 58.19 | 57.34 | 57.54 | 57.54 | 8,004,476 |
| Jul 7, 2026 | 57.79 | 58.49 | 57.45 | 57.97 | 57.97 | 10,048,425 |
| Jul 6, 2026 | 57.74 | 58.11 | 56.49 | 56.70 | 56.70 | 9,313,029 |
| Jul 2, 2026$0.63 dividend | 56.65 | 58.14 | 56.41 | 58.13 | 58.13 | 10,003,972 |
| Jul 1, 2026 | 57.62 | 57.70 | 56.30 | 56.44 | 55.84 | 11,201,803 |
| Jun 30, 2026 | 58.69 | 58.88 | 57.27 | 57.62 | 57.00 | 11,346,260 |
| Jun 29, 2026 | 57.61 | 58.58 | 57.17 | 58.56 | 57.93 | 11,770,946 |
| Jun 26, 2026 | 55.40 | 57.74 | 55.40 | 57.52 | 56.90 | 24,000,913 |
| Jun 25, 2026 | 55.37 | 56.19 | 55.02 | 55.39 | 54.80 | 15,981,429 |
| Jun 24, 2026 | 56.00 | 56.59 | 54.77 | 55.00 | 54.41 | 18,905,777 |
| Jun 23, 2026 | 55.39 | 55.94 | 54.96 | 55.53 | 54.94 | 13,250,980 |
| Jun 22, 2026 | 54.20 | 54.73 | 53.99 | 54.70 | 54.11 | 15,961,354 |
| Jun 18, 2026 | 55.20 | 55.33 | 53.44 | 54.00 | 53.42 | 31,700,381 |
| Jun 17, 2026 | 55.80 | 56.21 | 55.01 | 55.28 | 54.69 | 8,968,566 |
| Jun 16, 2026 | 56.41 | 56.62 | 55.45 | 55.92 | 55.32 | 11,945,740 |
| Jun 15, 2026 | 56.95 | 57.24 | 56.01 | 56.24 | 55.64 | 13,561,210 |
| Jun 12, 2026 | 57.45 | 57.60 | 56.77 | 57.13 | 56.52 | 7,840,637 |
| Jun 11, 2026 | 55.94 | 57.41 | 55.74 | 56.90 | 56.29 | 8,900,748 |
| Jun 10, 2026 | 56.64 | 56.70 | 55.60 | 55.60 | 55.00 | 8,146,820 |
| Jun 9, 2026 | 56.03 | 56.53 | 55.26 | 56.48 | 55.87 | 11,952,670 |
| Jun 8, 2026 | 57.16 | 57.42 | 55.53 | 55.57 | 54.97 | 12,344,654 |
| Jun 5, 2026 | 57.03 | 57.81 | 56.79 | 57.27 | 56.66 | 9,575,913 |
| Jun 4, 2026 | 55.74 | 56.78 | 55.55 | 56.60 | 55.99 | 12,659,116 |
| Jun 3, 2026 | 54.56 | 55.09 | 54.31 | 54.72 | 54.13 | 11,540,668 |
| Jun 2, 2026 | 54.78 | 55.59 | 54.20 | 54.46 | 53.88 | 13,739,876 |
| Jun 1, 2026 | 57.40 | 57.45 | 54.70 | 54.95 | 54.36 | 20,579,785 |
| May 29, 2026 | 57.00 | 57.33 | 56.53 | 57.18 | 56.57 | 27,567,581 |
| May 28, 2026 | 57.60 | 57.69 | 56.26 | 56.91 | 56.30 | 12,075,828 |
| May 27, 2026 | 58.03 | 58.80 | 57.13 | 57.52 | 56.90 | 9,348,014 |
| May 26, 2026 | 59.62 | 59.78 | 58.03 | 58.03 | 57.41 | 8,161,595 |
| May 22, 2026 | 59.97 | 60.25 | 59.25 | 59.46 | 58.82 | 6,489,774 |
| May 21, 2026 | 58.23 | 59.61 | 57.83 | 59.55 | 58.91 | 8,451,148 |
| May 20, 2026 | 58.67 | 59.21 | 58.11 | 58.54 | 57.91 | 8,547,167 |
| May 19, 2026 | 57.32 | 58.63 | 57.08 | 58.31 | 57.69 | 7,998,888 |
| May 18, 2026 | 57.45 | 58.50 | 57.08 | 57.31 | 56.70 | 11,659,255 |
| May 15, 2026 | 56.64 | 57.10 | 56.14 | 57.00 | 56.39 | 10,824,328 |
| May 14, 2026 | 56.69 | 57.05 | 56.10 | 56.77 | 56.16 | 7,686,960 |
| May 13, 2026 | 55.90 | 56.83 | 55.85 | 56.39 | 55.78 | 7,997,461 |
| May 12, 2026 | 56.01 | 57.02 | 55.45 | 56.45 | 55.84 | 9,274,358 |
| May 11, 2026 | 56.17 | 56.49 | 55.41 | 55.67 | 55.07 | 8,390,896 |
| May 8, 2026 | 56.33 | 56.53 | 55.77 | 56.16 | 55.56 | 10,033,020 |
| May 7, 2026 | 56.44 | 56.90 | 55.57 | 56.25 | 55.65 | 10,419,792 |
| May 6, 2026 | 57.23 | 57.40 | 56.36 | 56.59 | 55.98 | 10,439,381 |
| May 5, 2026 | 57.00 | 57.48 | 56.73 | 56.95 | 56.34 | 11,316,685 |
| May 4, 2026 | 57.65 | 58.00 | 56.93 | 57.38 | 56.77 | 9,447,370 |
| May 1, 2026 | 60.02 | 60.09 | 58.03 | 58.22 | 57.60 | 18,368,451 |
| Apr 30, 2026 | 57.69 | 60.78 | 57.39 | 60.59 | 59.94 | 24,880,099 |
| Apr 29, 2026 | 57.65 | 58.38 | 57.28 | 57.59 | 56.97 | 9,462,796 |
| Apr 28, 2026 | 58.58 | 58.73 | 57.91 | 58.26 | 57.63 | 6,271,039 |
| Apr 27, 2026 | 58.21 | 59.12 | 57.71 | 57.78 | 57.16 | 10,700,336 |
| Apr 24, 2026 | 58.86 | 59.21 | 58.34 | 58.71 | 58.08 | 6,822,839 |
| Apr 23, 2026 | 58.84 | 59.25 | 58.64 | 59.02 | 58.39 | 6,512,720 |
| Apr 22, 2026 | 59.40 | 59.70 | 58.68 | 58.80 | 58.17 | 7,500,202 |
| Apr 21, 2026 | 59.15 | 59.73 | 57.79 | 59.39 | 58.75 | 9,002,378 |
| Apr 20, 2026 | 60.00 | 60.12 | 58.91 | 59.13 | 58.50 | 7,678,094 |
| Apr 17, 2026 | 59.20 | 60.48 | 58.54 | 60.17 | 59.52 | 11,535,869 |
| Apr 16, 2026 | 57.67 | 58.98 | 57.66 | 58.96 | 58.33 | 8,220,669 |
| Apr 15, 2026 | 58.00 | 58.16 | 57.22 | 57.89 | 57.27 | 8,701,614 |
| Apr 14, 2026 | 57.90 | 58.62 | 57.56 | 58.08 | 57.46 | 7,612,946 |
| Apr 13, 2026 | 58.11 | 58.90 | 57.55 | 58.06 | 57.44 | 10,529,226 |
| Apr 10, 2026 | 59.79 | 59.80 | 58.46 | 58.62 | 57.99 | 8,060,099 |
| Apr 9, 2026 | 58.70 | 59.69 | 58.54 | 59.47 | 58.83 | 6,572,371 |
| Apr 8, 2026 | 58.01 | 59.23 | 57.67 | 59.20 | 58.56 | 11,587,575 |
| Apr 7, 2026 | 59.12 | 59.23 | 57.65 | 57.67 | 57.05 | 9,003,055 |
| Apr 6, 2026 | 59.12 | 59.63 | 58.77 | 59.33 | 58.69 | 7,954,315 |
| Apr 2, 2026$0.63 dividend | 60.23 | 60.58 | 59.10 | 59.60 | 58.96 | 14,752,811 |
| Apr 1, 2026 | 61.21 | 62.23 | 60.87 | 61.73 | 60.43 | 9,881,882 |
| Mar 31, 2026 | 60.20 | 61.13 | 59.92 | 60.65 | 59.37 | 12,797,240 |
| Mar 30, 2026 | 59.65 | 60.06 | 59.08 | 59.73 | 58.47 | 17,705,241 |
| Mar 27, 2026 | 59.61 | 59.69 | 58.37 | 58.54 | 57.31 | 7,909,293 |
| Mar 26, 2026 | 58.77 | 59.51 | 58.64 | 59.43 | 58.18 | 6,474,536 |
| Mar 25, 2026 | 57.79 | 59.39 | 57.79 | 58.94 | 57.70 | 9,052,195 |
| Mar 24, 2026 | 56.80 | 57.69 | 56.45 | 57.39 | 56.18 | 11,997,716 |
| Mar 23, 2026 | 58.22 | 58.25 | 57.00 | 57.00 | 55.80 | 10,129,913 |
| Mar 20, 2026 | 58.26 | 58.55 | 56.91 | 57.48 | 56.27 | 65,847,757 |
| Mar 19, 2026 | 59.21 | 59.64 | 58.09 | 58.11 | 56.89 | 12,850,610 |
| Mar 18, 2026 | 59.35 | 59.67 | 58.81 | 59.37 | 58.12 | 12,538,988 |
| Mar 17, 2026 | 60.13 | 60.80 | 59.59 | 59.71 | 58.45 | 14,258,037 |
| Mar 16, 2026 | 59.49 | 59.80 | 58.87 | 59.71 | 58.45 | 8,436,812 |
| Mar 13, 2026 | 59.67 | 60.06 | 58.75 | 59.08 | 57.84 | 9,395,591 |
| Mar 12, 2026 | 59.17 | 59.38 | 58.32 | 58.95 | 57.71 | 10,235,100 |
| Mar 11, 2026 | 60.00 | 60.03 | 59.27 | 59.98 | 58.72 | 9,043,759 |
| Mar 10, 2026 | 60.60 | 60.95 | 59.98 | 60.13 | 58.86 | 9,693,803 |
| Mar 9, 2026 | 59.92 | 60.64 | 59.25 | 60.63 | 59.35 | 10,964,649 |
| Mar 6, 2026 | 60.43 | 60.43 | 59.45 | 60.29 | 59.02 | 11,401,905 |
| Mar 5, 2026 | 61.80 | 61.99 | 60.26 | 60.74 | 59.46 | 14,758,365 |
| Mar 4, 2026 | 61.70 | 62.59 | 61.47 | 62.33 | 61.02 | 12,345,037 |
| Mar 3, 2026 | 61.57 | 61.95 | 60.43 | 61.22 | 59.93 | 12,425,292 |
| Mar 2, 2026 | 62.37 | 62.89 | 61.98 | 62.34 | 61.03 | 17,627,534 |
| Feb 27, 2026 | 61.18 | 62.67 | 61.18 | 62.37 | 61.06 | 20,742,639 |
| Feb 26, 2026 | 61.53 | 61.60 | 60.65 | 61.10 | 59.81 | 10,672,515 |
| Feb 25, 2026 | 61.50 | 62.12 | 60.91 | 61.30 | 60.01 | 16,234,065 |
| Feb 24, 2026 | 61.10 | 61.91 | 61.01 | 61.60 | 60.30 | 13,237,946 |
| Feb 23, 2026 | 60.97 | 61.44 | 60.64 | 61.25 | 59.96 | 11,029,067 |
| Feb 20, 2026 | 60.62 | 60.93 | 59.65 | 60.66 | 59.38 | 9,598,890 |
| Feb 19, 2026 | 59.85 | 60.36 | 59.23 | 60.30 | 59.03 | 13,325,223 |
| Feb 18, 2026 | 60.23 | 60.41 | 59.39 | 59.73 | 58.47 | 9,436,812 |
| Feb 17, 2026 | 60.85 | 61.30 | 59.48 | 60.35 | 59.08 | 12,874,351 |
| Feb 13, 2026 | 60.11 | 60.95 | 60.02 | 60.74 | 59.46 | 10,819,612 |
| Feb 12, 2026 | 60.00 | 60.93 | 59.25 | 59.86 | 58.60 | 14,021,477 |
| Feb 11, 2026 | 60.60 | 61.08 | 59.66 | 59.93 | 58.67 | 11,866,954 |
| Feb 10, 2026 | 60.94 | 61.45 | 59.95 | 60.86 | 59.58 | 12,082,761 |
| Feb 9, 2026 | 61.37 | 61.63 | 60.35 | 60.77 | 59.49 | 14,013,540 |
| Feb 6, 2026 | 60.00 | 62.05 | 59.77 | 61.99 | 60.68 | 17,117,629 |
| Feb 5, 2026 | 58.91 | 60.56 | 58.00 | 59.52 | 58.27 | 23,929,645 |
| Feb 4, 2026 | 56.57 | 57.97 | 56.43 | 57.62 | 56.41 | 21,793,765 |
| Feb 3, 2026 | 55.55 | 56.53 | 55.49 | 55.99 | 54.81 | 11,081,292 |
| Feb 2, 2026 | 55.06 | 55.90 | 54.96 | 55.89 | 54.71 | 9,424,892 |
| Jan 30, 2026 | 54.53 | 55.07 | 54.33 | 55.05 | 53.89 | 16,199,328 |
| Jan 29, 2026 | 54.64 | 55.17 | 54.21 | 54.28 | 53.14 | 16,530,095 |
| Jan 28, 2026 | 55.01 | 55.47 | 54.26 | 54.62 | 53.47 | 7,901,692 |
| Jan 27, 2026 | 54.56 | 56.12 | 54.56 | 55.56 | 54.39 | 11,346,998 |
| Jan 26, 2026 | 54.55 | 55.21 | 54.48 | 54.60 | 53.45 | 8,565,575 |
| Jan 23, 2026 | 54.98 | 55.18 | 54.23 | 54.65 | 53.50 | 9,701,819 |
| Jan 22, 2026 | 54.61 | 55.52 | 54.36 | 54.94 | 53.78 | 12,277,497 |
| Jan 21, 2026 | 54.10 | 54.62 | 53.55 | 54.50 | 53.35 | 15,834,800 |
| Jan 20, 2026 | 54.52 | 54.91 | 53.88 | 54.22 | 53.08 | 15,349,984 |
| Jan 16, 2026 | 56.46 | 56.56 | 55.10 | 55.26 | 54.10 | 13,702,877 |
| Jan 15, 2026 | 56.73 | 57.00 | 55.34 | 56.62 | 55.43 | 11,845,634 |
| Jan 14, 2026 | 56.11 | 57.04 | 55.73 | 57.02 | 55.82 | 13,352,616 |
| Jan 13, 2026 | 55.94 | 56.55 | 55.55 | 55.92 | 54.74 | 10,924,237 |
| Jan 12, 2026 | 56.11 | 56.59 | 55.51 | 55.77 | 54.59 | 13,249,559 |
| Jan 9, 2026 | 55.72 | 56.33 | 55.62 | 55.86 | 54.68 | 9,478,865 |
| Jan 8, 2026 | 56.58 | 56.97 | 55.81 | 55.90 | 54.72 | 12,073,510 |
| Jan 7, 2026 | 55.24 | 56.74 | 55.23 | 56.72 | 55.52 | 18,041,587 |
| Jan 6, 2026 | 53.20 | 54.82 | 53.15 | 54.42 | 53.27 | 16,769,436 |
| Jan 5, 2026 | 53.00 | 53.36 | 52.06 | 53.06 | 51.94 | 14,090,559 |
| Jan 2, 2026$0.63 dividend | 53.21 | 53.87 | 52.94 | 53.46 | 52.33 | 8,865,764 |
| Dec 31, 2025 | 54.21 | 54.35 | 53.91 | 53.94 | 52.19 | 7,866,758 |
| Dec 30, 2025 | 54.20 | 54.35 | 53.92 | 54.21 | 52.45 | 7,914,029 |
| Dec 29, 2025 | 54.64 | 54.73 | 54.00 | 54.11 | 52.35 | 9,162,766 |
| Dec 26, 2025 | 54.76 | 55.04 | 54.38 | 54.64 | 52.87 | 9,573,039 |
| Dec 24, 2025 | 54.41 | 54.74 | 54.20 | 54.71 | 52.93 | 10,038,136 |
| Dec 23, 2025 | 54.66 | 54.78 | 54.01 | 54.28 | 52.52 | 16,579,420 |
| Dec 22, 2025 | 54.14 | 54.81 | 54.04 | 54.66 | 52.88 | 25,146,303 |
| Dec 19, 2025 | 53.41 | 54.85 | 53.29 | 54.19 | 52.43 | 40,404,134 |
| Dec 18, 2025 | 53.31 | 53.80 | 53.09 | 53.33 | 51.60 | 17,296,458 |
| Dec 17, 2025 | 54.07 | 54.49 | 53.49 | 53.55 | 51.81 | 14,990,510 |
| Dec 16, 2025 | 54.25 | 54.72 | 53.40 | 54.23 | 52.47 | 18,038,372 |
| Dec 15, 2025 | 53.49 | 54.80 | 53.01 | 54.29 | 52.53 | 21,936,585 |
| Dec 12, 2025 | 52.27 | 52.99 | 52.01 | 52.41 | 50.71 | 19,046,726 |
| Dec 11, 2025 | 51.11 | 51.48 | 50.44 | 51.20 | 49.54 | 9,684,307 |
| Dec 10, 2025 | 50.79 | 51.61 | 50.33 | 51.21 | 49.55 | 12,132,410 |
| Dec 9, 2025 | 51.79 | 52.01 | 50.41 | 50.65 | 49.01 | 12,715,403 |
| Dec 8, 2025 | 52.20 | 52.41 | 51.66 | 51.67 | 49.99 | 15,278,685 |
| Dec 5, 2025 | 51.99 | 52.51 | 51.69 | 52.15 | 50.46 | 15,667,697 |
| Dec 4, 2025 | 50.80 | 52.08 | 50.23 | 51.95 | 50.26 | 20,473,113 |
| Dec 3, 2025 | 49.94 | 51.34 | 49.42 | 50.96 | 49.30 | 27,120,129 |
| Dec 2, 2025 | 48.95 | 49.18 | 48.22 | 48.25 | 46.68 | 14,475,664 |
| Dec 1, 2025 | 49.23 | 49.86 | 48.76 | 49.18 | 47.58 | 11,772,868 |
| Nov 28, 2025 | 49.23 | 49.37 | 49.01 | 49.20 | 47.60 | 6,187,103 |
| Nov 26, 2025 | 49.02 | 49.50 | 48.80 | 49.25 | 47.65 | 11,373,482 |
| Nov 25, 2025 | 48.21 | 49.40 | 48.10 | 49.05 | 47.46 | 14,999,966 |
| Nov 24, 2025 | 48.19 | 48.62 | 47.58 | 47.76 | 46.21 | 27,383,780 |
| Nov 21, 2025 | 46.17 | 46.99 | 45.52 | 46.25 | 44.75 | 14,183,520 |
| Nov 20, 2025 | 45.90 | 46.20 | 45.27 | 45.94 | 44.45 | 12,137,612 |
| Nov 19, 2025 | 47.00 | 47.00 | 45.74 | 45.79 | 44.30 | 14,825,040 |
| Nov 18, 2025 | 46.81 | 47.64 | 46.76 | 47.06 | 45.53 | 14,588,773 |
| Nov 17, 2025 | 46.52 | 47.73 | 46.52 | 46.81 | 45.29 | 12,851,577 |
| Nov 14, 2025 | 48.27 | 48.37 | 46.12 | 46.65 | 45.13 | 19,779,277 |
| Nov 13, 2025 | 49.02 | 49.99 | 48.48 | 48.63 | 47.05 | 14,502,621 |
| Nov 12, 2025 | 49.00 | 49.73 | 48.72 | 49.08 | 47.49 | 12,717,155 |
| Nov 11, 2025 | 47.48 | 48.74 | 47.45 | 48.72 | 47.14 | 14,446,012 |
| Nov 10, 2025 | 46.67 | 47.40 | 46.67 | 47.26 | 45.73 | 10,739,260 |
| Nov 7, 2025 | 46.72 | 46.99 | 46.32 | 46.69 | 45.17 | 9,007,501 |
| Nov 6, 2025 | 46.41 | 47.00 | 45.96 | 46.63 | 45.12 | 11,591,200 |
| Nov 5, 2025 | 45.55 | 46.63 | 45.42 | 46.47 | 44.96 | 11,730,681 |
| Nov 4, 2025 | 45.49 | 46.59 | 45.38 | 45.59 | 44.11 | 16,316,828 |
| Nov 3, 2025 | 46.20 | 46.66 | 45.51 | 46.02 | 44.53 | 20,374,696 |
| Oct 31, 2025 | 45.47 | 46.50 | 45.20 | 46.07 | 44.57 | 21,482,913 |
| Oct 30, 2025 | 43.27 | 45.82 | 43.20 | 45.62 | 44.14 | 41,931,628 |
| Oct 29, 2025 | 42.82 | 43.15 | 42.52 | 42.60 | 41.22 | 16,147,096 |
| Oct 28, 2025 | 43.39 | 43.39 | 42.75 | 42.82 | 41.43 | 17,960,554 |
| Oct 27, 2025 | 43.82 | 43.82 | 43.21 | 43.39 | 41.98 | 21,380,710 |
| Oct 24, 2025 | 43.93 | 43.94 | 43.58 | 43.83 | 42.41 | 10,105,883 |
| Oct 23, 2025 | 44.35 | 44.35 | 43.52 | 43.83 | 42.41 | 15,379,145 |
| Oct 22, 2025 | 44.59 | 45.23 | 44.33 | 44.39 | 42.95 | 14,316,510 |
| Oct 21, 2025 | 43.59 | 44.58 | 43.34 | 44.54 | 43.09 | 16,468,536 |
| Oct 20, 2025 | 43.66 | 43.98 | 43.51 | 43.59 | 42.17 | 11,511,456 |
| Oct 17, 2025 | 43.28 | 43.66 | 43.10 | 43.63 | 42.21 | 13,966,189 |
| Oct 16, 2025 | 43.73 | 43.93 | 43.22 | 43.39 | 41.98 | 12,922,142 |
| Oct 15, 2025 | 43.78 | 44.23 | 43.40 | 43.61 | 42.19 | 11,941,497 |
| Oct 14, 2025 | 43.43 | 43.90 | 43.27 | 43.80 | 42.38 | 16,805,617 |
| Oct 13, 2025 | 43.68 | 44.23 | 43.29 | 43.54 | 42.13 | 15,509,109 |
| Oct 10, 2025 | 44.78 | 44.78 | 43.77 | 43.96 | 42.53 | 14,024,948 |
| Oct 9, 2025 | 44.82 | 45.19 | 44.53 | 44.68 | 43.23 | 13,379,380 |
| Oct 8, 2025 | 44.74 | 44.90 | 44.45 | 44.54 | 43.09 | 10,822,949 |
| Oct 7, 2025 | 45.03 | 45.17 | 44.25 | 44.66 | 43.21 | 13,018,126 |
| Oct 6, 2025 | 45.35 | 45.91 | 44.87 | 45.14 | 43.67 | 19,162,528 |
| Oct 3, 2025$0.62 dividend | 45.20 | 46.17 | 44.66 | 45.45 | 43.97 | 17,893,954 |
| Oct 2, 2025 | 47.09 | 47.41 | 45.66 | 45.73 | 43.65 | 27,612,179 |
| Oct 1, 2025 | 46.00 | 48.58 | 45.64 | 47.43 | 45.27 | 36,615,437 |
| Sep 30, 2025 | 44.18 | 45.53 | 44.12 | 45.10 | 43.05 | 35,920,405 |
| Sep 29, 2025 | 44.00 | 44.67 | 43.78 | 44.15 | 42.14 | 20,722,930 |
| Sep 26, 2025 | 43.96 | 44.13 | 43.25 | 44.12 | 42.11 | 15,023,522 |
| Sep 25, 2025 | 44.18 | 44.46 | 43.19 | 43.41 | 41.44 | 21,345,589 |
| Sep 24, 2025 | 44.75 | 44.86 | 44.05 | 44.16 | 42.15 | 19,374,156 |
| Sep 23, 2025 | 44.92 | 45.59 | 44.71 | 44.91 | 42.87 | 16,358,138 |
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
Need daily prices for every ticker, in code?
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver API
Bristol-Myers Squibb Co. Executive Compensation
We estimate that -- received a compensation of -- in --, making them the highest paid executive at BMY, per a recent SEC DEF 14A filing.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|